The Directors bring to the Board relevant experience and skills, including industry and business knowledge, financial management and corporate governance experience.
Stuart Baxter – Chairman
Stuart is presently the Co-Fund Manager of Riverside Asia Fund. Stuart has led investment teams across three of Riverside’s funds. He originally launched Riverside Europe Fund and supervised all negotiations, legal due diligence and post-acquisition board work.
In 2000, Stuart transitioned to head Riverside’s San Francisco office as a Managing Partner of RCAF. In 2007 he launched Riverside’s Asia Fund.
Prior to joining Riverside in 1997, he was Director of Crimson Capital’s Czech Restructuring and Privatization Group for two years. Prior to that, Stuart was President of AI International Corporation, the U.S.-based holding company for a high-net-worth Kuwaiti family. He spent 12 years at AI International Corporation, managing various operating businesses, venture capital and real estate portfolios and executing over 30 acquisitions. Stuart began his career in investment banking in 1980 as an analyst at Credit Suisse First Boston.
Andrew Fox-Smith – Executive Director
Andrew Fox-Smith was appointed Chief Executive Officer on 20th June 2014 following the acquisition of Global Orthopaedic Technology by The Riverside Company – a leading mid cap private equity company.
As CEO, Andrew is responsible for the company’s overall management and global strategy. He has advised Riverside on a number of deals over the last 2 years and has over 20 years experience in the medical technology industry – including 18 years at Stryker Corporation where his most recent position was as Group President, International.
Andrew holds a Bachelor of Business from Charles Sturt University and has completed the Advanced Management Program at Harvard Business School. He is also Chairman of Optimized Ortho Pty Ltd – an innovative Australian based medical technology company specialising in dynamic, functional and patient specific simulations.
Michael Ribot – Non Executive Director
Michael Ribot is a co-founder of Global Orthopaedic Technology. Michael has a telecommunications engineering background; however, the Orthopaedic Market has been his focus for the past 30 years. Michael has worked closely with Australian surgeons in developing Global’s implant and instrument portfolios.
Dr William Walter – Special Advisor
Dr Walter is the founding partner and most senior orthopaedic surgeon at Sydney Hip & Knee Surgeons. He is a Fellow of the Australian Orthopaedic Association, former Chairman of the Division of Orthopaedic Surgery at the Mater Private Hospital, and former Chairman of the Medical Executive at the Mater Private Hospital.
Dr Walter is a long standing Fellow of the Royal Australasian College of Surgeons (FRACS), a Fellow of the Australian Orthopaedic Association, a founding member and past president of the Arthroplasty Society of Australia and a member of the Board for the Australian Institute of Musculo-Skeletal Research. Dr Walter’s interest in hip and knee replacement surgery began in the 1970s when it was first done in Australia; he has since done many thousands of joint replacements and is among the most respected surgeons in Australia.